Onco-Innovations (STU:W1H) Marketable Securities: €0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:W1H Onco-Innovations Ltd STU:W1H
12 GF Score
Price €0.33
! 2 Warning Signs
View Full Analysis

What is Onco-Innovations Marketable Securities?

Onco-Innovations STU:W1H -2.79% 12 Marketable Securities is €0.00 Mil as of Apr. 2026. GuruFocus rates STU:W1H with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Onco-Innovations's Marketable Securities for the quarter that ended in Apr. 2026 was €0.00 Mil.

Onco-Innovations  (STU:W1H) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Onco-Innovations Marketable Securities Related Terms

Onco-Innovations Marketable Securities Historical Data

* Premium members only.

The historical data trend for Onco-Innovations's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onco-Innovations Marketable Securities Chart

Onco-Innovations Annual Data
Trend Apr23 Apr24 Apr25 Apr26
Marketable Securities
0.00 0.00 0.00 0.00

Onco-Innovations Quarterly Data
Apr23 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:W1H
12GF Score
Onco-Innovations Ltd STU:W1H
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onco-Innovations Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.00 Mil mean?
Onco-Innovations (STU:W1H) has a Marketable Securities of €0.00 Mil as of Apr. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Onco-Innovations and its competitors.
Is Onco-Innovations' Marketable Securities too high?
Onco-Innovations' current Marketable Securities is €0.00 Mil. Overall, Onco-Innovations has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Onco-Innovations' Marketable Securities compare to VRTX and REGN?
Onco-Innovations' Marketable Securities of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Onco-Innovations and its competitors. Onco-Innovations's current Marketable Securities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onco-Innovations stock overvalued right now?
Onco-Innovations (STU:W1H) has a current Marketable Securities of €0.00 Mil. The current Marketable Securities is €0.00 Mil. Onco-Innovations' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Onco-Innovations (STU:W1H), the current Marketable Securities is €0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onco-Innovations Business Description

Other Exchanges ONCO:Canada
Address 7th Street South West, Suite 1039, Calgary, AB, CAN, T2R 1A5
Onco-Innovations Ltd is a pre-clinical stage biotechnology company working on developing drug candidates that can increase the effectiveness of current cancer treatments.
12GF Score

Get the complete analysis for STU:W1H

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price